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Klebsiella pneumoniae produces capsular polysaccharides that are a crucial virulence
factor protecting bacteria against innate response mechanisms of the infected host.
Simultaneously, those capsules are targeted by specific bacteriophages equipped with
virion-associated depolymerases able to recognize and degrade these polysaccharides.
We show that Klebsiella phage KP32 produces two capsule depolymerases, KP32gp37
and KP32gp38, with a high specificity for the capsular serotypes K3 and K21,
respectively. Together, they determine the host spectrum of bacteriophage KP32, which
is limited to strains with serotype K3 and K21. Both depolymerases form a trimeric
β-structure, display moderate thermostability and function optimally under neutral to
alkaline conditions. We show that both depolymerases strongly affect the virulence
of K. pneumoniae with the corresponding K3 and K21 capsular serotypes. Capsule
degradation renders the otherwise serum-resistant cells more prone to complement-
mediated killing with up to four log reduction in serum upon exposure to KP32gp37.
Decapsulated strains are also sensitized for phagocytosis with a twofold increased
uptake. In addition, the intracellular survival of phagocytized cells in macrophages
was significantly reduced when bacteria were previously exposed to the capsule
depolymerases. Finally, depolymerase application considerably increases the lifespan of
Galleria mellonella larvae infected with K. pneumoniae in a time- and strain-dependent
manner. In sum, capsule depolymerases are promising antivirulence compounds that
act by defeating a major resistance mechanism of K. pneumoniae against the innate
immunity.
Keywords: bacteriophage, Klebsiella sp., capsule, polysaccharide depolymerase, innate immunity
INTRODUCTION
With the emergence of both hypervirulent and multidrug-resistant strains, Klebsiella pneumoniae
infections have now become a serious global health concern, especially threatening the health
of hospitalized and immune-compromised patients (Podschun and Ullmann, 1998; Paczosa and
Mecsas, 2016; Martin and Bachman, 2018). Most K. pneumoniae strains are enveloped by a
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thick capsular polysaccharide (CPS), which plays an important
role in processes critical for the pathogenicity of these bacteria.
Based on CPS diversity 78 serologically distinct capsule variants
(K-types) of K. pneumoniae have been described (Pan et al.,
2013). However, this number is certainly an underestimation
of this diversity as large genomics studies have described 134
capsular K-types, which are easily transferable by homologous
recombination between K. pneumoniae strains (Wyres et al.,
2016). The serotype-associated differences in the capsule
thickness and its glycan composition affect Klebsiella virulence
(Cryz et al., 1986), e.g., higher amounts of produced CPS
relate to a higher virulence (Nassif and Sansonetti, 1986).
Moreover, Klebsiella capsule structure may lack some glyco-
epitopes that could be recognized by components of the
host’s innate defense, including the mannose-receptor (MR) of
macrophages, mannose-binding lectin (MBL) or lung surfactants
proteins (Sahly et al., 2008). In addition, capsule loss or alteration
of both the composition and amount of produced CPS, either
by knocking out any gene necessary for its production or by
treatment with capsule-degrading agents, can lead to attenuation
of virulence (Yoshida et al., 2000; Cortés et al., 2002; Lawlor et al.,
2005).
Due to its external position, the CPS modulates the pathogen-
host interface, both in the context of the interactions between
the bacterium and the human immune system, and between
the phage and the bacterium as a host. By masking underlying
cell surface structures, CPS allows the bacterial cell to hide
from the host defense system and evade its destructive power,
which is crucial in the establishment of infection. Indeed,
poorly capsulated K. pneumoniae strains or capsule-deficient
mutants are more efficiently phagocytized by macrophages
and neutrophils than heavily capsulated and wild-type strains,
respectively (Álvarez et al., 2000; Cortés et al., 2002; Lawlor et al.,
2005; Regueiro et al., 2006; March et al., 2013). Furthermore,
CPS covering the O-antigen of lipopolysaccharide (LPS) or
the outer membrane proteins (OMPs) as well as the other
antibody epitopes on the bacterial cell surface, can also suppress
the complement cascade activation, thereby preventing C3b
deposition and membrane attack complex (MAC) formation
(Merino et al., 1992; Albertí et al., 1996).
Phages are commonly found in the biosphere and as
natural bacterial predators control its abundance in all kind
of environments (marine, freshwater, soil, microbiome of
multicellular organisms). On the other hand, bacteria as natural
prey of phages have developed several strategies to prevent phage
infection or to diminish its consequences (Olszak et al., 2017).
One of phage-resistance mechanism is to inhibit virion
adsorption to bacterial surface by the production of
polysaccharide thick layer such as capsule, slime or biofilm
matrix. Thus besides evasion of phagocytic- and complement-
mediated killing, CPS serve bacteria for the protection against
viral infection. Nevertheless, some phages developed a specific
strategy to overcome this barrier. To gain access to the membrane
and to trigger DNA ejection, Klebsiella phages first recognize,
bind to and enzymatically degrade CPS of bacterial cell, using
virion-associated proteins with depolymerization activity. These
structural enzymes, called capsule depolymerases, are mainly
found in tail fibers or tail spikes, structures that also determine
the phage host range (Latka et al., 2017). Phages have evolved
various capsule depolymerases, providing them with diverse
bacteria specificities. For instance, nine functional capsule
depolymerase-encoding genes were identified in the genome
of Klebsiella giant phage K64-1 with each depolymerase able
to degrade a different CPS type (K1, K11, K21, K25, K30/K69,
K35, K64, KN4, and KN5), (Pan et al., 2015, 2017). In turn,
the closely related podoviruses K5-2 and K5-4 encode tail fiber
proteins with K30/K69 and K5, or K8 and K5 depolymerase
activities, respectively (Hsieh et al., 2017). In another study, two
genes encoding putative CPS depolymerases were identified in
podovirus KpV41 (Solovieva et al., 2018).
With the exhausting number of bacterial targets that could
be the basis for novel antibiotic drug development, the
interest in antivirulent agents including phage-encoded enzymes,
has emerged as a promising strategy for infection control
(Majkowska-Skrobek et al., 2016; Olszak et al., 2017; Maciejewska
et al., 2018). Unlike conventional antibiotics that kill the bacterial
cells or inhibit their growth, the capsule depolymerases are
aimed at disarming the pathogen. Modification of the bacterial
phenotype makes the cells less virulent and more susceptible to
antimicrobials or innate host defense (Bansal et al., 2014; Lin
et al., 2014; Pan et al., 2015). In this paper, we identified two
proteins encoded by Klebsiella phage KP32 (Podoviridae, KP32
virus), the tail spike and a previously hypothetical protein that
are able to degrade two different capsular serotypes. We analyzed
their effect on K. pneumoniae virulence including the capsule-
mediated resistance to complement action and phagocytosis by
human macrophages as well as the susceptibility to the insect
innate immune response in Galleria mellonella infection model.
MATERIALS AND METHODS
Phage, Bacterial Strains, and Growth
Conditions
Phage vB_KpnP_KP32 (KP32; PCM F/00068) was originally
isolated from environmental water in Poland and characterized
in our previous paper (Ke¸sik-Szeloch et al., 2013). The Klebsiella
pneumoniae strains used in this study (Supplementary Table S1)
are provided by the Institute of Genetics and Microbiology
Bacterial Collection (Wroclaw, Poland). Klebsiella strains were
routinely cultured in Trypticase Soft Broth or Agar (TSB or TSA,
BioMérieux, Marcy-l’Etoile, France) at 37◦C. Unless indicated
otherwise, the overnight cultures were diluted 1/100 in fresh
TSB and incubated for 2 h at 37◦C with shaking to log-phase.
Then the cultures were harvested (5,000 × g, 20 min, 4◦C)
and resuspended to an OD600 of 1.0 in PBS (∼109 CFU/ml).
Capsular serotype was determined by sequencing of wzi or wzc
genes as described elsewhere (Brisse et al., 2013; Pan et al.,
2013). Escherichia coli TOP10 F’ and BL21(DE3) (Invitrogen,
Carlsbad, CA, United States) were used for plasmid propagation
and recombinant protein expression, respectively. E. coli strains
were cultivated in Lysogeny Broth (LB, BioCorp, Lublin, Poland)
at 37◦C supplemented with 100 µg/ml ampicillin. All bacteria are
listed in Supplementary Table S1.
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Recombinant Protein Preparation and
Characterization
The open reading frames of phage KP32 DNA encoding gp37
(YP_003347555), and gp38 (YP_003347556) were amplified
by PCR using Pfu DNA polymerase (Thermo Fisher Scientific,
Lithuania) and specific primer pairs (Supplementary Table S1),
and then cloned into the pEXP5-NT/TOPO R© and pEXP5-
CT/TOPO R© expression vectors (Invitrogen, Carlsbad, CA,
United States), respectively. Following verification by DNA
sequencing (Genomed, Warsaw, Poland), E. coli BL21(DE3) was
transformed with the correct plasmids, and overproduction of
the recombinant proteins in LB supplemented with 100 µg/ml
ampicillin was induced by the addition of isopropyl-β-D-
thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM
for 18 h at 20◦C. The cells were harvested (5,000 × g, 20 min,
4◦C), resuspended in lysis buffer [300 mM NaCl, 20 mM Tris-
HCl, 10 mM imidazole, 5% (v/v) glycerol, pH 7.8] containing
complete protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany), and were lysed by freezing/thawing
and sonication. Recombinant His-tagged proteins were then
purified from the soluble fractions of the whole-cell lysates
by affinity chromatography using Bio-Scale Mini Profinity
IMAC cartridges (Bio-Rad, Hercules, CA, United States) in
combination with a FPLC-system (Bio-Rad, Hercules, CA,
United States) as previously described (Majkowska-Skrobek
et al., 2016). Proteins were dialyzed against phosphate-buffered
saline (PBS) buffer (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4) using Float-A-Lyzer
(Serva, Heidelberg, Germany), and analyzed by 12% SDS-PAGE
according to the method of Laemmli (1970) and size-exclusion
chromatography (SEC) coupled to a miniDAWN TREOS multi-
angle static light scattering (MALS) detector (Wyatt Instrument
Technology Corp., Santa Barbara, CA, United States) and an
OptilabTM rEX (Wyatt Instrument Technology Corp.). Circular
dichroism studies were carried out as described previously
(Majkowska-Skrobek et al., 2016). Protein concentrations were
measured fluorometrically (Qubit 2.0, Invitrogen, Carlsbad,
CA, United States) or spectrophotometrically (NanoDrop, 2000
Spectrophotometer, Thermo Fisher Scientific) using a molar
extinction coefficient of 107,730 cm−1·M−1 (for KP32gp37) and
63,620 cm−1·M−1 (for KP32gp38) estimated by ProtParam1.
Visualization of phage KP32 and recombinant depolymerases
specificities on bacterial lawns was performed using a standard
spot assay (Majkowska-Skrobek et al., 2016).
Depolymerase Stability Measurement
To estimate the pH-dependent stability, depolymerase was
suspended at the desired pH, using 50 mM CH3COONa-HCl
buffer (pH 3.0–5.0), 50 mM NaH2PO4-Na2HPO4 buffer (pH 6.0–
7.0), and 50 mM Tris-HCl buffer (pH 8.0–9.0), and incubated
for 30 min at 37◦C. For thermostability analysis the enzyme
was incubated in 50 mM NaH2PO4-Na2HPO4 buffer (pH 7.4)
at temperatures ranging from 18◦C to 80◦C for 30 min. The
residual activity of the enzyme was then evaluated according to
1http://web.expasy.org/protparam
method adapted from Augustyniak et al. (2012), with the ortho-
nitrophenyl-α-D-galactopyranoside (ONPG, Sigma, St. Louis,
MO, United States) as substrate. The reaction mixture was
composed of 150 µg/ml depolymerase and 3 mM ONPG in
PBS in a total volume of 150 µl. After 90 min of incubation at
37◦C, the absorbance at 405 nm of ortho-nitrophenol released
from the chromogenic substrate was measured (Asys UVM340,
Biochrom Ltd., Cambourne, United Kingdom). Relative enzyme
activity was calculated and expressed as a percent reduction of
absorbance compared with the control. As a control we used the
depolymerase diluted in PBS, that was incubated at 4◦C. The
negative controls were runs with buffers and ONPG, but without
the enzyme. Each experiment was performed in triplicate and
repeated at least twice.
To assess the enzyme susceptibility to anionic detergent (SDS,
sodium-dodecyl sulfate) and proteolytic degradation by trypsin,
the samples containing 100 µg/ml of protein were incubated
in the buffer (50 mM NaH2PO4-Na2HPO4, pH 7.0), and 1%
(w/v) SDS (Bio-Rad, Hercules, CA, United States) or 1% (w/v)
trypsin (Gibco BRL, Paisley, United Kingdom) for 10 min at RT
or 100◦C and at 37◦C for 1 h, respectively. Further the protein
samples were mixed with Laemmli buffer (Bio-Rad, Hercules,
CA, United States), and analyzed with SDS-PAGE as heated and
unheated samples.
Extraction and Quantification of
Capsular Polysaccharide
The total CPS was extracted from equal numbers of bacteria
which were grown on TSA plates without and in the presence of
enzyme for 48 h at 37◦C, following the procedure of Domenico
et al. (1989). Briefly, bacteria from the halo zones and lawns
were scrapped from plates, washed with PBS and centrifuged
(20,000 × g, 30 min, 4◦C). The pellet was suspended in 2 ml
of 0.1% Zwittergent 3–14 detergent (Calbiochem, Darmstadt,
Germany) in 50 mM citric acid (pH 4.5) and heated at 42◦C
for 30 min. After centrifugation (17,700 × g, 10 min, 4◦C), the
supernatant was transferred to a new tube and absolute ethanol
was added to a final concentration of 80% (v/v). The mixture
was placed overnight at –20◦C. Followed by centrifugation, the
supernatant was decanted and the pellet was dissolved in 2 ml
of distilled water. The CPS concentration was quantified by
the uronic acid assay (Blumenkrantz and Asboe-Hansen, 1973),
using a standard curve of D-glucuronic acid (Sigma-Aldrich, St.
Louis, MO, United States), and expressed as µg per 109 CFU.
Serum Resistance Assay
Pooled normal human serum (NHS) was purchased from the
Regional Center of Transfusion Medicine and Blood Bank
(Wroclaw, Poland) and stored at −80◦C. This was conducted
according to the principles expressed in the Law on the public
service of blood of May 20, 2016 and in the Directive 2002/98/EC
of the European Parliament and of the Council of January
27, 2003, establishing standards of quality and safety for the
collection, testing, processing, storage, and distribution of human
blood and blood components. To determine serum sensitivity of
enzyme-treated bacteria, ∼8 × 105 CFU of log phase bacteria
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were suspended in PBS without or with the enzyme (at the final
concentrations of 0.1 µg/ml, 1 µg/ml, 10 µg/ml or 100 µg/ml),
and mixed at a 1:1 v/v ratio with either pooled NHS or heat-
inactivated NHS (56◦C, 30 min). The mixture in final volume
of 200 µl was incubated for 7 h at 37◦C, and at 0, 1, 2, 3,
5, and 7 h intervals, 20 µl aliquots were removed, diluted and
cultured on TSA for colony enumeration. In some experiments,
10 µl of a fresh dose of depolymerase at the concentration of
1,000 µg/ml was added after 3 h and 5 h of incubation. Each test
was performed at least in three independent experiments.
Phagocytosis Assays
Phagocytosis assays were performed according to protocols
adapted from Augustyniak et al. (2012, 2015) with some
modifications.
(i) Monocyte Culture and Macrophage Differentiation
Human monocyte/macrophage cell line THP1 (ATCC, TIB-
202) was maintained in RPMI-1640 medium (Lonza, Verviers,
Belgium) supplemented with 10% heat-inactivated fetal bovine
serum (HIFBS; GIBCO, Life Technologies, Grand Island, NY,
United States), 1× glutamax (GIBCO, Life Technologies, Grand
Island, NY, United States) and 1× antibiotic-antimycotic solution
(GIBCO, Life Technologies, Grand Island, NY, United States)
at 37◦C in a 5% CO2 atmosphere. To induce monocyte-to-
macrophage differentiation, THP-1 cells were harvested and
seeded into to 96-well-flat-bottom microplates (NUNC, Thermo
Fisher Scientific, Roskilde, Denmark) at density 5 × 105 cells/ml
(105 cells per well) in complete growth medium containing
20 ng/ml of phorbol-12-myristate-13-acetate (PMA, Sigma-
Aldrich, St. Louis, MO, United States). After 24 h incubation
at 37◦C in a humidified 5% CO2 atmosphere, the medium was
replaced on PMA- and antibiotic-antimicotic-free medium and
cells were cultured a further 24 h before use for phagocytic
experiments.
(ii) Fluorescence Labeling of Klebsiella Strains
Washed bacteria (ca. 109 CFU) were suspended in 200 µl of
PBS without or with depolymerase (400 µg/ml). After 2 h
incubation at 37◦C, bacteria were harvested by centrifugation at
5,000× g for 15 min at 4◦C and resuspended in 1 ml of PBS. For
fluorescent labeling bacteria were killed by UV for 1 h (Osram
Germicidal Puritec HNS 30W G13, Russia) and subsequently
incubated with 1 mg/ml of fluorescein isothiocyanate (FITC,
Thermo Fischer Scientific, Rockford, IL, United States) in 0.05
M carbonate/bicarbonate buffer (pH 9.5) at 37◦C for 30 min
with gentle mixing in the dark. To remove the excess of
dye, FITC-conjugated bacteria were washed twice with ice-cold
carbonate/bicarbonate buffer, resuspended in PBS and stored at
−80◦C until further use.
(iii) Uptake of FITC-Labeled Bacteria
A 50 µl of UV-killed FITC-labeled, untreated or depolymerase-
treated bacteria in Hank’s Balanced Salt Solution Ca2+Mg2+
buffer (HBSS-Ca2+Mg2+; Lonza, Verviers, Belgium)
supplemented with 1% HIFBS were added to 50 µl of non-
adherent THP-1 cells (107 cells/ml) in the same buffer to get
a MOI of 100:1. After 2 h incubation at 37◦C in a humidified
5% CO2 atmosphere, the cells were placed on ice to halt
phagocytosis and then treated with 0.2 mg/ml of trypan blue
solution to quench extracellular fluorescence. As a negative
phagocytic control, each bacterial strain and phagocytic cells
combination was also kept on ice to block endocytic uptake
of bacteria. For analysis by flow cytometry on a FACS Calibur
(Becton Dickinson), the samples were diluted 1:1 in ice-cold
HBSS-Ca2+Mg2+ followed by two washes in the same buffer.
Each assay was performed at least three times in duplicate. The
THP-1 effector cells were selected according to their forward
and side scatter properties using THP-1 cells alone as a control.
Data from 10,000 events (cells) per condition were collected and
analyzed using Flowing Software (version 2.5.1).
(iv) Phagocytosis by THP-1 Differentiated
Macrophages
On the day of experiments, the plates containing differentiated
macrophages were washed twice with HBSS-Ca2+Mg2+ and
50 µl of untreated and depolymerase-treated bacteria in RPMI-
1640 with 8% FBS was added to each well in duplicates to get
a MOI of 0.1 in a final volume of 0.2 ml. The culture plates
were then centrifuged at 200 × g for 3 min at RT to synchronize
phagocytosis and incubated under 5% CO2 at 37◦C for 2 h. After
phagocytosis, infected monolayers were rinsed twice with HBSS-
Ca2+Mg2+ and then incubated for additional 1 h with 200 µl
RPMI-1640 containing 10% FBS, gentamicin (300 µg/ml; ICN
Biomedicals, Eschwege, Germany) and polymyxin B (15 µg/ml;
Sigma-Aldrich, St. Louis, MO, United States) to eliminate non-
ingested bacteria. To determine the intracellular bacterial load,
cells were lysed with 200 µl of 0.05% trypsin/0.08% saponin
solution (v/v) for 10 min with shaking, followed by five-time
washing with 200 µl of PBS each time. The lysates were then
transferred to 1.5 ml Eppendorf tubes and vortexed vigorously
for 30 s. The bacteria were plated in 10-fold serial dilutions onto
TSA plates in triplicates and incubated overnight at 37◦C. The
intracellular bacterial load is presented as CFU per well. All assays
were repeated at least three times. Controls were carried out by
incubating bacteria in RPMI without macrophages.
Galleria mellonella Killing Assay
Culture and infection of wax moth larvae (Galleria mellonella)
with K. pneumoniae strains as well as the estimation of the
survival rate of infected larvae was performed as outlined
previously by Majkowska-Skrobek et al. (2016). Briefly, larvae
were infected by injection directly into the hemocoel with
107 CFUs of: (i) depolymerase-untreated bacteria, (ii) bacteria
preincubated for 2 h at 37◦C with depolymerase at final
concentration of 200 µg/ml, and (iii) bacteria administered
together with the enzyme (200µg/ml). Three control groups were
included: uninfected larvae, sham injected larvae with PBS and
larvae injected with enzyme to monitor the background larval
mortality, the killing due to injection trauma, and the killing due
to the toxicity of the enzyme, respectively. Larvae survival was
recorded for 72 h post-injection with 24 h intervals. Each test was
performed in three independent experiments with 10 larvae per
trial.
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Statistical Analysis
Comparisons between any two experimental groups were made
by the two-sample Student’s t-test or, when the requirements
were not met, by the Mann–Whitney U test. Survival curves
were plotted using the Kaplan–Meier method, and the analysis
in survival was performed by using the log-rank Mantel-Cox.
P < 0.05 was considered statistically significant. All analyses were
performed using GraphPad Prism software (GraphPad Software
Inc.).
Accession Number
Genome sequence of the phage KP32 (vB_KpnP_KP32) has been
deposited in GenBank/EMBL under accession no. NC_013647.
RESULTS
Klebsiella Phage KP32 Encodes Two
Proteins With Capsular Polysaccharide
Degrading Activity
Protein-based screening of databases on the presence of amino
acid sequence and structural homology with polysaccharide-
degrading enzymes resulted in the identification of two ORFs
(gp37 and gp38) in Klebsiella phage KP32 genome, encoding a
tail fiber protein and a hypothetical protein, respectively. Analysis
of the gp37 gene product (hereafter as KP32gp37) with SMART2
and InterProScan3 revealed an N-terminal phage_T7_tail domain
(Pfam03906; AA: 7-150; e = 1.02e-39), pectate_lyase_3 domain
(Pfam12708; AA: 301-507; e = 1.13e-05) and a C-terminal
peptidase_S74 domain (Pfam13884; AA: 770-825; e = 1.49e-
11) (Figure 1). The N-terminal domain exhibits high sequence
similarity to the N-terminal 150 residues of other tail spikes
belonging to podoviruses from “T7-like genus,” “KP32 viruses”
and myoviruses that infect Klebsiella. Moreover, the C-terminal
region has significant sequence identity to chaperone, domain of
endosialidases present in the form of tail spikes or tail fibers of
E. coli-specific phages. The protein encoded by the second ORF
(KP32gp38) shows 99% similarity and 87% identity to a tail spike
protein of Klebsiella phage K5 (YP_009198669).
In turn, a screening of the Protein Data Bank (PDB) database
using HHPred and Phyre2 revealed a moderate homology of
KP32gp37 to an exo-poly-α-D-galacturonosidase (PDB code
3jur), and KP32gp38 to pectin lyase-like superfamily and
glycoside hydrolase family 28, enzyme groups (PDB code
1bhe) which may be both involved in polysaccharides and
oligosaccharides processing.
Biophysical and Biochemical Properties
of KP32gp37 and KP32gp38 Proteins
The expressed KP32gp37 and KP32gp38 proteins were
purified to electrophoretic homogeneity using two-step
purification procedures (by Ni-NTA affinity and gel filtration
chromatography). Purified KP32gp37 and KP32gp38 migrate
2http://smart.embl-heidelberg.de
3http://www.ebi.ac.uk/Tools/pfa/iprscan/
as single bands on SDS-PAGE and have an estimated size of
approximately 83 kDa and 62 kDa, respectively (Supplementary
Figure S1A). The shorter observed length for KP32gp37
compared to predicted (Table 1) is likely due to the self-removal
of the C-terminal, without affecting its activity. The purified
proteins were further analyzed by SEC coupled with MALS
to determine the their oligomerization state in solution. An
estimated molecular weight of 259.5± 0.52 kDa and 179.4± 0.54
kDa was observed under native conditions for KP32gp37 and
KP32gp38, respectively (Supplementary Figures S1B,C). Given
the theoretical mass of the monomers (Table 1), confirmed
under the denaturing conditions of SDS-PAGE, these findings
clearly indicate a trimeric organization of both proteins. Besides
the same oligomerization state, both proteins have also the
same secondary structure content, as evidenced by the strong
overlapping of both CD traces (Supplementary Figure S1D).
The pronounced minimum at 218 nm and a positive maximum
between 195 and 200 nm point to correctly folded proteins with a
high β-sheet content. To gain insight into the secondary structure
changes under the heat, the thermal unfolding profiles of these
proteins were studied using CD spectroscopy. The thermal
unfolding curve of the KP32gp37 exhibits a sigmoidal transition
with a relatively high melting temperature (Tm = 74◦C), while
the thermal stability of KP32gp38 (Tm = 56◦C) is relatively low
compared to KP32gp37 (Supplementary Figure S1E).
The activity of KP32gp37 and KP32gp38 was visualized in
serial dilutions by a spot assay (Figure 2A). The translucent
halo zones on the Klebsiella lawns following spotting of both
recombinant proteins confirm their distinct enzymatic activity
against different capsular types. KP32gp37 creates halo zones,
even when 2 µl of enzyme (0.1 µg/ml) was dropped on a lawn
of K. pneumoniae 271, representing capsular serotype K3. Similar
halo zones were seen after KP32gp38 application on isolates
corresponding to the capsular serotype K21 (strains 358 and
968). In the case of strain 45, the halo zone was visible at a 10-
fold higher concentration of KP32gp38. Spot test revealed also
that phage KP32 caused lytic infections and plaque formation
on Klebsiella strains with both capsular types. Subsequently, to
estimate the depolymerase-mediated reduction of the capsular
material, the concentration of glucuronic acid was determined by
the uronic acid assay in CPSs extracted from bacteria cultured for
2 days both in the presence and lack of the enzyme (Figure 2B).
The amounts of CPS produced by the specific depolymerase-
treated strains 271, 45, 358, and 968 ranged between 13.2 and
29.3 µg of glucuronic acid/109 bacteria and remained 4.5- to 13-
fold lower compared to the amount of CPS obtained from the
equal number of untreated bacterial cells (from to 71.3 µg/109
cells to 221 µg/109 cells, P < 0.05).
Beyond the confirmation of their biological activity, KP32gp37
and KP32gp38 have been studied in detail for their stability
at various pH values and temperatures, tolerance to anionic
detergent, and resistance to proteolytic degradation. Both
enzymes revealed an optimal stability under slightly alkaline
conditions from pH 7.0 to 9.0, maintaining 74.8 ± 0.8%
to 100.0 ± 0.6% their activity, respectively (Supplementary
Figure S2A). After an incubation for 1 h under acidic
conditions (pH 6.0 and below), less than 30% of their
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FIGURE 1 | Bioinformatic sequence analysis of KP32gp37 and KP32gp38. BlastP analyses of the gp37 and gp38 gene products are presented in the boxes
beneath the corresponding genes.
TABLE 1 | Structural and biological properties of KP32gp37 and KP32gp38.
Properties KP32gp37 KP32gp38 Method used
Capsular-type specificity K3 K21 Spot test
Number of amino acids 869 578 ExPASy - ProtParam tool
Theoretical pI 5.28 7.57 ExPASy - ProtParam tool
Predicted molecular mass (kDa) 95.35 61.87 ExPASy - ProtParam tool
Oligomeric state (kDa) 259.5 ± 0.52 179.4 ± 0.54 Size-exclusion chromatography coupled with light scattering
Secondary structure Mainly β-sheet Mainly β-sheet CD spectroscopy
Melting temperature (Tm) 74◦C 56◦C CD spectroscopy
Thermostability Up to 45◦C Up to 50◦C ONPG assay
pH stability 4–9 6–9 ONPG assay
Susceptible to SDS Resistant Sensitive Electrophoresis
Susceptible to proteolysis Resistant Sensitive Electrophoresis
FIGURE 2 | The activity of recombinant KP32gp37 and KP32gp38 proteins. (A) The spot test with the serial dilutions from 0.1 to 100 µg/ml of depolymerases and
phage KP32 on K. pneumoniae (KP) strains capsular types of K3 or K21. The translucent halo zones and a clear plaque were observed after overnight incubation at
37◦C when 2 µl of recombinant proteins or phage (106 PFUs) were spotted on bacterial lawn, respectively. (B) Total CPS production by Klebsiella strains grown on
TSA plates in depolymerase absence or presence for 48 h at 37◦C, determined in the uronic acid assay. Data represents the mean of two independent experiments
(mean ± SEM). Asterisks indicate statistically significant differences (∗P < 0.05) when compared with enzyme-untreated bacteria.
original activity was preserved. In addition, both enzymes
remain active over the temperature range from 18◦C to 45◦C,
maintaining more than 95% of their activity (Supplementary
Figure S2B). At 50◦C KP32gp38 displayed more than 90%
of its activity, while the KP32gp37 activity dropped to
16.7± 1.1%.
Based on electrophoretic mobility of proteins, it has been
shown that these depolymerases differ in sensitivity to both
anionic detergent and protease. KP32gp37 is resistant against
denaturation by SDS at room temperature and against digestion
by trypsin (Supplementary Figure S2C). By contrast, KP32gp38
was found to be sensitive to both SDS-induced denaturation and
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FIGURE 3 | Time-dependent bactericidal effect of serum against K. pneumoniae strains 271 (A), 45 (B) and 358 (C) treated and untreated with a capsule
serotype-specific and non-specific depolymerase. Bacteria were grown in 50% NHS or heat inactivated NHS, in the presence or absence of depolymerases for 7 h
at 37◦C. Serially diluted aliquots were plated on TSA plates. The results were expressed as mean ± SEM. As the survival of Klebsiella strains treated and untreated
of a capsule serotype-specific enzyme in the presence of heat inactivated NHS was comparable, so for simplicity, only one of these data has been shown. Asterisks
indicate statistically significant differences (∗P < 0.05, ∗∗P < 0.001) compared to the initial inoculum. For each option, at least three independent experiments were
performed.
proteolytic cleavage. Table 1 summarizes biochemical properties
and structural features in solution of both depolymerases.
Depolymerase Influence on
K. pneumoniae Sensitivity to
Complement-Mediated Killing
The susceptibility of K. pneumoniae to the bactericidal activity
of serum depends on the structure and organization of both
CPS and the LPS O-side chain (Álvarez et al., 2000; Cortés
et al., 2002). Of the four clinical Klebsiella strains analyzed
by us, three were characterized as serum resistant showing a
survival of 100% or even a propagation event after 7 h of
incubation in 50% NHS (Figure 3). Klebsiella strain 968 was
sensitive to NHS killing with a reduction of CFU in the range
of six orders after 30 min of incubation (data not shown). To
define the influence of depolymerase-induced degradation of
CPS on the survival of serum-resistant strains, the complement
bactericidal assays were performed in the presence of enzymes.
The treatment of strains with a capsule serotype-specific enzyme
produced a time-dependent decline in survival, while bacteria
treated with non-specific enzyme (100 µg/ml) or incubated only
in the presence of NHS were protected from the lytic effect of
complement. For K3-type strain (271), 0.1 µg/ml of KP32gp37
caused a decrease of bacterial number, respectively, by 1.6 order
of magnitude upon 3 h exposure (from 2.54 × 106 ± 4.80 × 104
CFU/ml to 4.04 × 104 ± 6.90 × 103 CFU/ml, P < 0.05) and
almost four orders upon 7 h (from 2.54 × 106 ± 4.80 × 104
CFU/ml to 7.33 × 102 ± 8.82 × 101 CFU/ml, P < 0.001)
(Figure 3A). Increasing KP32gp37 concentration to 100 µg/ml
did not significantly affect the sensitivity of bacteria to the
bactericidal action of serum. In contrast, K21-type strains showed
only 1.7- to 4.6-fold CFU reduction compared to the initial
inoculum upon 3 h exposure to KP32gp38 at 100 µg/ml in
the presence of NHS (from 2.22 × 106 ± 8.66 × 104 CFU/ml
to 1.34 × 106 ± 1.49 × 105 CFU/ml for strain 45 and from
2.16 × 106 ± 1.0 × 105 CFU/ml to 4.86 × 105 ± 5.30 × 104
CFU/ml for strain 358), (Figures 3B,C). The prolongation of
the incubation time up to 7 h resulted in a further gentle
CFU reduction of strain 358 (to 1.87 × 105 ± 3.13 × 104
CFU/ml), while the strain 45 has not increased its susceptibility
to complement action, even if the fresh doses of KP32gp38
were added after 3 and 5 h. The bacterial number of strain 45
remained at the level of 1.26 × 106 ± 2.34 × 105 CFU/ml,
whereas after the administration of two additional doses of
enzyme was 7.52 × 105 ± 9.85 × 104 CFU/ml. When bacteria
were incubated with or without enzyme in the presence of
heat-inactivated NHS, no killing was observed for any of tested
strains, suggesting that the killing was effectively due to the lytic
action of complement. These findings indicate that the increase
in complement activity against depolymerase-treated Klebsiella
cells is corresponding to the serotype-related variations of CPS
structure.
Exposure to Depolymerase Sensitizes
Klebsiella Cells to Phagocytosis
To study whether the depolymerase-induced degradation of
bacterial CPS affects phagocytosis by THP1 cells, we used two
different methods. The first one was flow cytometric analysis
in which the quantitative uptake of UV-killed FITC-labeled
K. pneumoniae strains by monocytes, was determined. Untreated
or enzyme-treated bacterial cells were compared. The second
method was the classical bacteriological method, in which THP1
differentiated macrophages infected with bacteria were lysed
for intracellular bacterial quantification. The geometric Mean
Fluorescence Intensity (gMFI) of monocytes after a 120-min
incubation with enzyme-treated bacteria, at an infection ratio
of 100 bacteria per cell, was significantly higher than of cells
incubated with untreated bacteria (P < 0.05), (Figures 4A,B).
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FIGURE 4 | Depolymerase-mediated phagocytosis of K. pneumoniae strains by the human monocyte cell line THP1 determined by flow cytometry (A,B) and plate
counting (C). Representative flow cytometric plots: (A) histograms depict increased uptake of depolymerase-treated bacteria vs. untreated bacteria. UV-killed
FITC-labeled K. pneumoniae (KP) strains 271, 358, 968, 45 and ATCC (non-K3/K21 serotype used as a control), preincubated or not with corresponding
depolymerase, were mixed with monocytes at 100:1 ratio. Black peaks show the log of fluorescence intensity of monocytes exposed to depolymerase-treated
K. pneumoniae strains; gray peaks depict log fluorescence intensity of monocytes exposed to untreated bacterial cells. (B) Quantification of ingested
depolymerase-treated or untreated bacteria labeled with FITC by monocytes as measured by flow cytometry and analyzed using Flowing Software. Data are
expressed as the geometric mean fluorescence intensity (gMFI) from the gated sample with phagocytozing cells ± SEM. Results are representative of three
independent experiments. (C) Quantification of intracellular bacteria in THP1-differentiation macrophages infected with Klebsiella cells in the present or without
corresponding depolymerase. The number of surviving bacteria was determined by macrophage lysis and colony count. Data represent the mean ± SEM of
CFU × 103/well from three independent experiments performed in duplicate (n = 6). Asterisks indicate statistically significant differences (∗P < 0.05) when compared
to corresponding controls (no depolymerase, gray bars).
KP32gp37 enhanced the uptake of strain 271 nearly twofold,
from 91.0 ± 3.5 gMFI for untreated to 167.3 ± 8.3 gMFI
for enzyme-treated bacteria. Similar results were obtained for
the uptake of two strains possessing degraded capsules by the
second depolymerase. KP32gp38 treatment increased the uptake
of strain 358 from 83.9 ± 5.7 gMFI to 146.7 ± 13.6g gMFI,
whereas these values for strain 968 were 102.3 ± 6.8 gMFI and
293.6 ± 24.4 gMFI, respectively. Likewise, when K. pneumoniae
cells were phagocytized by THP1 differentiated macrophages in
the presence of serotype-specific depolymerase, their intracellular
bacterial load was considerably reduced (up to 52%) compared
to enzyme-untreated bacteria. That proves the effective killing
of pathogens with degraded capsular layer, especially when
considering that a higher number of cells is taken up when the
capsule is depolymerized (Figure 4C). These results suggest that
depolymerases, likely by uncovering ligands for phagocytic cell
attachment, can defeat the resistance of encapsulated bacteria to
phagocytosis and sensitize them to the uptake and killing in this
process.
Depolymerase Application Prolongs the
Survival of Klebsiella Infected Wax Moth
Larvae
As the immune system of G. mellonella larvae in many
aspects is remarkably similar to the innate immune response
of the higher organisms to Klebsiella infections (Insua et al.,
2013), we used the insect model to evaluate the virulence of
depolymerase-preincubated bacterial cells as well as the efficacy
of treatment with these enzymes in vivo. For three out of four
tested Klebsiella strains, an injection of bacteria pretreated with
a capsule serotype-specific depolymerase as well as a single
dose of the enzyme administered simultaneously with bacteria
significantly affected the larval survival rate compared to the
bacteria injected groups (P < 0.05) (Figure 5). The anti-K3
depolymerase (KP32gp37) was able to prolong the larvae survival
of at least 13% after 24 h post-infection and the treatment
exposition profiles were similar to each other. The application
of KP32gp38 was very effective on two K21-strains (358 and
968) regardless of the type of infection treatment (preincubated
bacteria or bacteria plus enzyme). In this case, the survival rates
of larvae were at least 30% higher comparing to the control after
24 h post-infection. Moreover, at least 50 and 70% of larvae
inoculated 358 and 968 strains, respectively, were alive at the
end of the experiment (72 h) (P < 0.001). Unexpectedly, the
K21-strain 45 turned out to be in vivo almost fully insensitive to
depolymerase activity. No mortality of larvae was observed in the
control groups, upon injection of PBS buffer or enzyme alone.
In general, we may state that depolymerase treatment can rescue
larvae against bacterial infection indicating that these enzymes
are able to attenuate the Klebsiella virulence in a time- and strain
dependent manner.
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FIGURE 5 | Kaplan–Meier survival curves following injection of G. mellonella larvae with K. pneumoniae strains (A) 271, (B) 968, (C) 358 and (D) 45. Larvae were
injected with either bacteria (107 CFUs/per larvae), bacteria preincubated with serotype-specific depolymerase or enzyme administrated simultaneously with
bacteria. Larvae survival was monitored for 3 days post injection. The experiments were controlled by uninfected larvae, PBS-injected larvae and larvae receiving the
enzyme only. Survival for each control group was 100%, so for simplicity, these groups were not included in the figure. Data represent three independent
experiments with a total of 30 larvae per bacterial strain. Statistically significant differences in survival were calculated by the log-rank test.
DISCUSSION
Capsule, a major factor for Klebsiella virulence and phage
susceptibility, is a crucial element in the phage-bacterium-
host interplay. In the present study, we have evaluated two
newly characterized depolymerases derived from Klebsiella phage
KP32 (KP32gp37 and KP32gp38), exhibiting the capacity to
recognize and digest the capsules from strains representing
K3 and K21 serotypes, respectively. We addressed two major
questions: (i) can these phage-encoded enzymes counteract the
resistance of encapsulated K. pneumoniae to key mechanisms
of the innate host defense such as complement-mediated lysis
and phagocytosis by macrophages, and (ii) if so, what is the
role of the capsular serotype and depolymerase specificity?
We have demonstrated that depolymerase-induced capsule
degradation, effectively disarms the pathogen, resulting in
complement-mediated killing, increased phagocytosis and killing
by macrophages. In addition, the depolymerases are highly
specific for a particular capsule serotype. Considering the
potential of these phage-encoded proteins as antivirulence
compounds, we also determined biochemical and biophysical
properties of both enzymes.
In our study, the specificities of KP32gp37 and KP32gp38
against encapsulated bacteria were validated based on in vitro
spot assays and quantitative determination of glucuronic acid in
capsular material extracted from bacteria growing in the presence
of enzyme. In contrast to phage KP32 that causes lytic infection
and halo zone formation on bacterial lawns of both K3 and all
K21 strains, each of the proteins possesses CPS depolymerization
activity toward only one capsular serotype. The presence of two
CPS depolymerases in the KP32 genome thus expands the host
spectrum of phage KP32.
The capacity of K. pneumoniae to circumvent the immune
response mechanisms ensures the supremacy of the pathogen
over the host and contributes to a successful infection process.
Previous studies pointed to at least two mechanisms that
contribute to capsule-mediated resistance to complement action.
The first mechanism is the masking effect of CPS on bacterial
molecules that act as targets for complement activation and
deposition. These molecules include: (i) the epitopes on the
bacterial surface that are necessary for classical pathway (CP)
activation in an antibody-dependent manner, (ii) the OMPs
that can trigger the CP in antibody-independent manner upon
interaction with C1q component, (iii) LPS that allows the
deposition of C3b in three activation pathways (Merino et al.,
1992; Albertí et al., 1993, Albertí et al., 1996; Doorduijn et al.,
2016). The second mechanism is correlated to the serotype-
related differences in capsular composition and the ability of
some strains to modify the polysaccharide backbone. It was
shown that MBL fail to recognize CPS deprived of mannobiose
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or rhamnobiose repeating units, thereby inhibiting the lectin
pathway (LP), with the subsequent reduced deposition of C3b
and cell lysis (Sahly et al., 2009).
Our results showed that in response to the bactericidal
action of serum, the number of KP32gp37-treated K3 bacteria
was significantly decreased compared with non-treated or
bacteria incubated with or without enzyme in the presence of
heat-inactivated NHS. The survival of KP32gp38-treated K21
Klebsiella strains merely decreased a 2- to 11-fold. However,
the remaining amounts of CPS present in depolymerase-treated
bacteria were an average sixfold lower than those of their
encapsulated parental strains and maintained at a similar level,
regardless of the enzyme serotype specificity. Analyzing above
results we may suspect that only following CPS degradation
of K3-type, the complement components gained access to
activators on the cell surface (porins and rough LPS), leading
to increased deposition of C3b on-serum resistant cells and the
C5-9 MAC formation, which resulted in killing of pathogen.
In general it might be concluded that Klebsiella capsular
serotype is more important for protection against complement-
mediated killing than the amount of CPS produced by cells
following depolymerase treatment. The repeating units of both
K3 and K21 CPSs are the pyruvic acetal-bearing pentasaccharide
containing mannose, galactose, and glucuronic acid in a ratio
of 3:1:1 and 2:2:1, respectively (Dutton and Choy, 1972; Dutton
et al., 1986). Thus, even slight differences in capsule sugar
composition determine bacterial susceptibility to phage-derived
depolymerase. This unique specificity of the enzymes allows them
to be used in targeted therapy against Klebsiella strains with
defined serotype. On the other hand, it is possible to extend
the substrate spectrum for such enzymes (Simpson et al., 2015).
It was shown that both changing of residues in the active site
by mutation and swapping with foreign domains, already active
on a selected polysaccharide, enables to generate enzymes with
changed substrate specificity (Barbirz et al., 2008; Leiman and
Molineux, 2008). It is worth noting that, despite the presence
of mannobiose participating in LP activation, serum-resistance
of all strains tested in this work (except for strain 968) suggests
that this pathway is not a dominant or sufficient to kill them by
complement.
To further characterize the innate response against
depolymerase-treated bacteria, we assessed their capacity to
trigger non-opsonic (lectino-)phagocytosis. Unlike the observed
differences between serotypes in terms of their ability to
resist complement following depolymerase treatment, such
dependency was not seen for the susceptibility to phagocytosis.
We proved that UV-killed depolymerase-treated bacteria of both
serotypes were more effectively taken up by THP1 monocytes
than the unmodified parent bacteria, excluding strain 45. Also
the number of the bacterial cells killed by THP1 monocyte-
derived macrophages was significantly higher after modification
of their phenotype by capsule-specific enzymes. Depolymerase-
mediated, enhanced uptake may be explained by the nature
of the sugar residues present in CPS. Some K. pneumoniae
serotypes display surface glycans with terminal mannose residues
that are recognized by the mannose receptor of macrophages,
thereby acting as a marker of non-self (Wileman et al., 1986;
Athamna et al., 1991; Sahly et al., 2008). Upon recognition,
the receptor internalizes the bound pathogen and transports
it to lysosome for degradation via the phagocytic pathway.
The strains of both serotypes studied in this work (K3 and
K21) possess internal mannosyl residues in their CPS structures
(Dutton and Choy, 1972; Dutton et al., 1986). Thus, the increased
susceptibility to phagocytosis after depolymerase treatment may
be explained by a concomitant increased exposure of previously
inaccessible mannose residues to the macrophage receptors.
On the other hand, the increased uptake of depolymerase-
treated cells by monocytes, which do not express the mannose
receptor (Shepherd et al., 1982), indicates that other receptors
or mechanisms may be involved in this process. Therefore, even
for strains bearing glyco-epitopes in their capsule promoting
lectinophagocytosis, enzymatic removal of CPS barrier improves
this process, probably by an appropriate presentation and
accessibility of ligands to phagocytic cell receptors.
An important question is whether in vivo capsule
removal by phage-derived depolymerase would improve
the susceptibility of bacteria to the host’s immune response. Lin
et al. (2014) demonstrated that intraperitoneal administration
of recombinant depolymerase encoded by a K1-specific phage,
NTUH-K2044-K1-1, significantly increased the survival rate of
mice pre-treated with cyclophosphamide and then infected with
K. pneumoniae NTUH-K2044. Similar therapeutic efficacy of a
K64 specific depolymerase has been shown in cyclophosphamide-
treated mice infected with multidrug-resistant K. pneumoniae,
although this enzyme was ineffective if administrated 8 h
post-infection (Pan et al., 2015). Given that cyclophosphamide
reduce leucocytes counts without affecting the level of serum
complement (Li et al., 1987), these observations suggest that
complement-dependent mechanism is responsible for clearance
of enzyme-treated bacteria and protection for infection. Also in
our study, it has been demonstrated a significant prolongation
of the larvae lifespan following the infection of bacteria
preincubated with a capsule serotype-specific depolymerase
or an application of enzyme to treat infected caterpillars. It
proves that these phage-derived proteins are able to reduce
Klebsiella virulence in in vivo model. Nevertheless, for some
strains (Klebsiella 45 of K21 serotype) the degradation of capsule
by phage-derived depolymerase did not significantly affect the
phagocytic uptake implicating further unsuccessful infection
treatment in moth larvae model.
Exposed on the surface of the virion, tail spikes or fibers bind
specific sequences of carbohydrates to recognize the bacterial
host cell (Drulis-Kawa et al., 2015), thus their structures must be
stable to oppose the harsh environmental conditions, i.e., high
temperatures, non-physiological pH, the presence of extracellular
proteases, etc., to keep phage infectivity (Barbirz et al., 2008).
Many tail spikes and fibers obtain stability through the formation
of a trimeric β-structure, resembling a puncturing needle
(Steinbacher et al., 1994; Kanamaru et al., 2002; Weigele et al.,
2003). In addition to trimer formation, other attractive properties
of both tested proteins are their moderate thermostability up to
74◦C and 56◦C and maximum activity under slightly alkaline
conditions in the range pH values from 7.0 to 9.0, similar to
most Klebsiella phage-derived depolymerases (Bessler et al., 1973;
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Kassa and Chhibber, 2012). In contrast, these enzymes can be
differentiated in terms of resistance to anionic detergent and
proteolytic cleavage.
CONCLUSION
We demonstrated that two depolymerases encoded by Klebsiella
phage KP32 degrading capsules of K3 and K21 serotypes, are
able to sensitize bacteria to serum complement lysis, increase
an uptake and killing of K. pneumoniae by macrophages in the
lectinophagocytosis process as well as are effective in in vivo
infection model in a serotype- and strain-dependent manner. In
general, these enzymes have beneficial properties for its further
application in therapy or for biotechnology purposes.
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